Expression of c-myc mRNA in Hepatocellular Carcinomas, Noncancerous Livers, and Normal Livers | Citedby Results | Pathobiology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Expression of c-myc mRNA in Hepatocellular Carcinomas, Noncancerous Livers, and Normal Livers

Pathobiology (2004) 71 (5): 281–286.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Coriolic Acid (13-(S)-Hydroxy-9Z, 11E-octadecadienoic Acid) from Glasswort (Salicornia herbacea L.) Suppresses Breast Cancer Stem Cell through the Regulation of c-Myc

Yu-Chan Ko
Hack Sun Choi
Ji-Hyang Kim
Su-Lim Kim
Bong-Sik Yun
Dong-Sun Lee

Molecules (2020) 25 (21): 4950.

Multiplexed determination of intracellular messenger RNA by using a graphene oxide nanoprobe modified with target-recognizing fluorescent oligonucleotides

Hongyan Jiang
Fu-Rong Li
Wei Li
Xiaodong Lu
Kai Ling

Microchimica Acta (2018) 185 (12)

2‐D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis

Ramdzan M. Zubaidah
Gek San Tan
Sandra B. E. Tan
Seng Gee Lim
Qingsong Lin
Maxey C. M. Chung

PROTEOMICS (2008) 8 (23-24): 5086.

Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma

F. Farinati
R. Cardin
M. Bortolami
P. Burra
F. P. Russo
M. Rugge
M. Guido
A. Sergio
R. Naccarato

Journal of Viral Hepatitis (2007) 14 (12): 821.

Expression of C‐Myc mRNA in squamous cell carcinoma of the tongue

Hemangini H. Vora
Neelam G. Shah
Trupti I. Trivedi
Jignesh V. Goswami
Shilin N. Shukla
Pankaj M. Shah

Journal of Surgical Oncology (2007) 95 (1): 70.

Immunohistochemical expression of CD95 (Fas), c‐myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma

A. EL‐BASSIOUNI
M. NOSSEIR
M. ZOHEIRY
E. EL‐AHWANY
A. GHALI
N. EL‐BASSIOUNI

APMIS (2006) 114 (6): 420.

Oxidative damage, pro-inflammatory cytokines, TGF-α and c-myc in chronic HCV-related hepatitis and cirrhosis

Fabio Farinati

World Journal of Gastroenterology (2006) 12 (13): 2065.

HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL

Anita Pathil
Sorin Armeanu
Sascha Venturelli
Paolo Mascagni
Thomas S. Weiss
Michael Gregor
Ulrich M. Lauer
Michael Bitzer

Hepatology (2006) 43 (3): 425.